Psychiatry and Neurology, Neurology · Roseville, MN
NPI
1386871614
Since 2009
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2720 Fairview Ave N Ste 100
Roseville, MN, 55113
Phone (651) 241-5290
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
396 services
Medicare patients, 2024
191
Average age 63
Drug cost, 2024
$1.3M
3,323 prescriptions
Company payments, 2025
$77.16
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Palak Shah was code 95720 (neurologic), 174 times for 92 patients. In total Palak Shah billed 396 services in 22 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 174 | 92 | $154.61 | $27K |
| 99214 Office E&M - Established | Office | 79 | 66 | $84.29 | $6,659 |
| 99213 Office E&M - Established | Office | 26 | 26 | $54.63 | $1,420 |
| 95718 Neurologic | Facility | 24 | 23 | $97.69 | $2,345 |
| 99232 Hospital E&M - Subsequent | Facility | 24 | 16 | $59.29 | $1,423 |
| 95816 Neurologic | Facility | 11 | 11 | $42.89 | $472 |
By year: 2022 $46K for 371 services; 2023 $47K for 415 services; 2024 $48K for 396 services.
Medicare prescription drug claims, 2024
In 2024, the drug Palak Shah prescribed most often to Medicare patients was Levetiracetam, with 565 prescriptions and refills. In total Palak Shah wrote 3,323 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 565 | 891 | 90 | $27K |
| Lacosamide Generic | 307 | 339 | 35 | $38K |
| Lamotrigine Generic | 288 | 365 | 31 | $9,979 |
| Briviact Brivaracetam | 219 | 240 | 22 | $454K |
| Divalproex Sodium Er Divalproex Sodium | 198 | 244 | 20 | $12K |
| Clobazam Generic | 155 | 167 | 16 | $18K |
| Zonisamide Generic | 139 | 169 | 16 | $8,412 |
| Felbamate Generic | 130 | 161 | 15 | $49K |
| Topiramate Generic | 125 | 144 | Under 11 | $6,642 |
| Pregabalin Generic | 101 | 107 | Under 11 | $3,857 |
| Lamotrigine Er Lamotrigine | 98 | 116 | Under 11 | $33K |
| Oxcarbazepine Generic | 96 | 139 | 15 | $6,084 |
| Carbamazepine Generic | 87 | 96 | Under 11 | $2,728 |
| Divalproex Sodium Generic | 77 | 100 | 11 | $5,179 |
| Levetiracetam Er Levetiracetam | 70 | 152 | 19 | $5,203 |
Brand drugs: 461 claims; generic drugs: 2,836 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Palak Shah $77.16 ($77.16 in general payments such as food, travel and fees) from 1 company. The largest payer was Jazz Pharmaceuticals Inc. with $77.16.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $77.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.